NYSE:PTN
Palatin Technologies Inc Stock News
$1.82
+0.100 (+5.81%)
At Close: Apr 26, 2024
Palatin Technologies, Inc. (PTN) Reports Q1 Loss, Tops Revenue Estimates
10:32am, Monday, 14'th Nov 2022
Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of 35.82% and 8.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the
Solid Biosciences Inc. (SLDB) Reports Q3 Loss, Lags Revenue Estimates
01:55pm, Thursday, 10'th Nov 2022 Zacks Investment Research
Solid Biosciences Inc. (SLDB) delivered earnings and revenue surprises of -4.63% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stoc
Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates
11:45pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Armata Pharmaceuticals, Inc. (ARMP) delivered earnings and revenue surprises of 11.11% and 3.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for t
Palatin to Report First Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on November 14, 2022
05:16pm, Wednesday, 09'th Nov 2022
CRANBURY, N.J., Nov. 9, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter fiscal year 2023 operating results on Monday, November 14, 2022, before th
Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates
12:25am, Wednesday, 09'th Nov 2022 Zacks Investment Research
Seer, Inc. (SEER) delivered earnings and revenue surprises of 0% and 6.60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
YmAbs Therapeutics, Inc. (YMAB) Reports Q3 Loss, Tops Revenue Estimates
10:15pm, Monday, 07'th Nov 2022 Zacks Investment Research
YmAbs Therapeutics, Inc. (YMAB) delivered earnings and revenue surprises of 16% and 7.29%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stoc
Swedish Orphan Biovitrum (BIOVF) Beats Q3 Earnings Estimates
11:05am, Thursday, 27'th Oct 2022 Zacks Investment Research
Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 16.67% and 2.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the
Palatin: Inhibitor Drug With Potential In Several Autoimmune Disorders
03:25pm, Wednesday, 05'th Oct 2022
PL9643 is being explored in a phase 3 study treating patients with Dry Eye Disease; Results from this late-stage study are expected in Q2 of 2023. The global dry eye disease market is expected to beco
Palatin to Report Fourth Quarter and Fiscal Year End 2022 Results; Teleconference and Webcast to be held on September 22, 2022
04:15pm, Monday, 19'th Sep 2022
CRANBURY, N.J. , Sept. 19, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2022 operating results on Thursday, September 22, 2
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
05:53am, Monday, 19'th Sep 2022 Benzinga
Gainers
Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares climbed 50.4% to settle at $3.76 on Friday after
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
08:13am, Friday, 09'th Sep 2022 Benzinga
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to sharehol
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
09:29am, Friday, 02'nd Sep 2022 Benzinga
Gainers
Hempacco Co., Inc. (NASDAQ: HPCO) shares jumped 63.4% to close at $8.35 after dropping 34% on Wednesday. Hempacco's common shares began trading on the Nasdaq Tuesday. The company had planned
Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session
04:47pm, Thursday, 01'st Sep 2022 Benzinga
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) jumped 94.4% to $27.24. ShiftPixy announced a 1-for-100 reverse stock split.
Hempacco Co., Inc. (NASDAQ: HPCO) shares climbed 63% to $8.33 after dropping 34% on
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
06:33am, Monday, 22'nd Aug 2022 Benzinga
Gainers
GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday.
Aeglea BioTherapeutics, Inc. (NASDAQ:
Aldeyra's (ALDX) Dry Eye Disease Chamber Study Meets Goals
02:53pm, Wednesday, 13'th Jul 2022 Zacks Investment Research
Aldeyra's (ALDX) vehicle-controlled crossover study evaluating 0.25% reproxalap ophthalmic solution for the treatment of dry eye disease meets primary endpoints. Shares up.